Samira Farouk is a Nephrology physician affiliated with Mount Sinai Hospital. OpenAlex indexes 95 publications with 2,329 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 E 98th St Fl 12
New York, NY 100296501
Telephone
212-659-8086Registry record last updated 3 May 2019.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- CALLIDITAS THERAPEUTICS US INC.Program year20241 payment
- GENZYME CORPORATIONProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
45.7%alpha-Adrenergic Blocker45.7%Tamsulosin Hcl100%Part D<11 patientsCardiovascular
28.3%Calcium channel blocker28.3%Amlodipine Besylate100%Part D<11 patientsMetabolism & gastrointestinal
26.1%H2 blocker26.1%Famotidine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2026 per NIH RePORTER. The latest:
- 6/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
Weill Medical Coll of Cornell Univ
FY2026$195,256U01DK116100 - 6/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
Weill Medical Coll of Cornell Univ
FY2025$275,687U01DK116100 - 6/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
Weill Medical Coll of Cornell Univ
FY2024$320,000U01DK116100
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Estimation of multicomponent flow in the kidney with multi‐<i>b</i>‐value spectral diffusion
Magnetic Resonance in Medicine
2025 - Recommendations to overcome barriers to transplant fellowship training: A report from the American Society of Transplantation Fellows Task Force
American Journal of Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Allison McGeer
Mount Sinai Hospital
Scott Sicherer, MD
Mount Sinai Hospital
Ulrich Specks
Mount Sinai Hospital
Jorge Sánchez‐Guerrero
Mount Sinai Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”